Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Machine-learning analysis of intrinsically disordered proteins identifies key factors that contribute to neurodegeneration-related aggregation. | Front Aging Neurosci | 2022 | 35992603 | PubTator, text mining | PubMed |
| Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: Implication, prospects, and perspectives. | Front Immunol | 2022 | 35990673 | PubTator, text mining | PubMed |
| A novel chemokine-based signature for prediction of prognosis and therapeutic response in glioma. | CNS Neurosci Ther | 2022 | 35985661 | PubTator, text mining | PubMed |
| Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer. | Front Immunol | 2022 | 35979353 | PubTator, text mining | PubMed |
| First report of a short in-frame biallelic deletion removing part of the EGF-like domain calcium-binding motif in LTBP4 and causing autosomal recessive cutis laxa type 1C. | Am J Med Genet A | 2022 | 35972031 | PubTator, text mining | PubMed |
| Microfluidic-Derived Detection of Protein-Facilitated Copper Flux Across Lipid Membranes. | Anal Chem | 2022 | 35969432 | PubTator, text mining | PubMed |
| Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma. | Front Oncol | 2022 | 35965536 | PubTator, text mining | PubMed |
| Relative Bioavailability of Trace Minerals in Production Animal Nutrition: A Review. | Animals (Basel) | 2022 | 35953970 | PubTator, text mining | PubMed |
| The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma. | Front Genet | 2022 | 35942287 | PubTator, text mining | PubMed |
| Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy. | Front Cell Dev Biol | 2022 | 35938165 | PubTator, text mining | PubMed |
| Discovery of novel natural products as dual MNK/PIM inhibitors for acute myeloid leukemia treatment: Pharmacophore modeling, molecular docking, and molecular dynamics studies. | Front Chem | 2022 | 35936081 | PubTator, text mining | PubMed |
| Cuproptosis-Related Gene - SLC31A1, FDX1 and ATP7B - Polymorphisms are Associated with Risk of Lung Cancer. | Pharmgenomics Pers Med | 2022 | 35923305 | PubTator, text mining | PubMed |
| Newly identified disorder of copper metabolism caused by variants in CTR1, a high-affinity copper transporter. | Hum Mol Genet | 2022 | 35913762 | PubTator, text mining | PubMed |
| Sensitization of cancer cells towards Cisplatin and Carboplatin by protein kinase D inhibitors through modulation of ATP7A/B (copper transport ATPases). | Cancer Treat Res Commun | 2022 | 35908410 | PubTator, text mining | PubMed |
| Circular RNA circPBX3 promotes cisplatin resistance of ovarian cancer cells via interacting with IGF2BP2 to stabilize ATP7A mRNA expression. | Hum Cell | 2022 | 35907138 | PubTator, text mining | PubMed |
| Copper in the tumor microenvironment and tumor metastasis. | J Clin Biochem Nutr | 2022 | 35903604 | PubTator, text mining | PubMed |
| Introduction to serial reviews: Copper biology in health and disease. | J Clin Biochem Nutr | 2022 | 35903600 | PubTator, text mining | PubMed |
| The Role of Metals in the Neuroregenerative Action of BDNF, GDNF, NGF and Other Neurotrophic Factors. | Biomolecules | 2022 | 35892326 | PubTator, text mining | PubMed |
| MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin. | Int J Mol Sci | 2022 | 35886942 | PubTator, text mining | PubMed |
| Design, Synthesis and Evaluation of Novel Phorbazole C Derivatives as MNK Inhibitors through Virtual High-Throughput Screening. | Mar Drugs | 2022 | 35877722 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=40